Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this research is to determine how gender affirming hormone therapy affects muscle physiology.


Clinical Trial Description

Study participation involves a screening visit and two study visits. The screen includes blood draws, and urine testing. The first visit requires a collection of breath, exercise testing, and body scans. Between visits participant are to eat three days of provided meals and wear an activity monitor. The second study visit will be 3-14 days after the first and includes blood draws, a meal test, and a muscle biopsy. If individuals are not on gender affirming hormone therapy at the time of participation, they may be able to participate again if you decide to pursue gender affirming hormone therapy later on. ;


Study Design


NCT number NCT06083766
Study type Observational
Source Mayo Clinic
Contact Jennifer R Hewlett, M.D.
Phone 507-266-9479
Email Hewlett.Jennifer@mayo.edu
Status Recruiting
Phase
Start date January 4, 2024
Completion date July 2026